

Description | A biologically active disulfide-linked homodimeric protein consisting of two 166 residues polypeptide chains with Met at N-terminal of VEGFA. Source: E. coli Amino Acid Sequence: MAPMAEGGGQ NHHEVVKFMD VYQRSYCHPI ETLVDIFQEY PDEIEYIFKP SCVPLMRCGG CCNDEGLECV PTEESNITMQ IMRIKPHQGQ HIGEMSFLQH NKCECRPKKD RARQENPCGP CSERRKHLFV QDPQTCKCSC KNTDSRCKAR QLELNERTCR CDKPRR |
PreparationMethod | Novus' biologically active proteins are stringently purified to provide only the safest and most highly effective proteins available. This protein was expressed in E. coli, purified by HPLC, QC tested by SDS-PAGE and Western Blot and validated on appropriate cell lines for bioactivity. All HPLC and bioactivity data is provided for your assurance. |
Details of Functionality | VEGF 165 protein is fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells(HUVEC) is between 1.0-8.0 ng/ml. |
Source | E. coli |
Protein/Peptide Type | Recombinant Protein |
Gene | VEGFA |
Purity | >95% pure by SDS-PAGE |
Endotoxin Note | Less than 1 EU/ug of endotoxin as determined by LAL method. |
Theoretical MW | 38.6 (homodimer) kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. | |
Publications |
|